Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
87.5M
-
Number of holders
-
140
-
Total 13F shares, excl. options
-
68.6M
-
Shares change
-
+2.88M
-
Total reported value, excl. options
-
$1.26B
-
Value change
-
+$54.2M
-
Put/Call ratio
-
0.31
-
Number of buys
-
58
-
Number of sells
-
-67
-
Price
-
$18.33
Significant Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q2 2022
169 filings reported holding KURA - Kura Oncology, Inc. - Common Stock as of Q2 2022.
Kura Oncology, Inc. - Common Stock (KURA) has 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.6M shares
of 87.5M outstanding shares and own 78.44% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (6.64M shares), BlackRock Inc. (4.96M shares), Avoro Capital Advisors LLC (4.8M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (4.02M shares), Deep Track Capital, LP (3.7M shares), VANGUARD GROUP INC (3.33M shares), Holocene Advisors, LP (3.26M shares), BVF INC/IL (3.2M shares), STATE STREET CORP (3.03M shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.63M shares).
This table shows the top 140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.